7 results match your criteria: "University of North Carolina Charlotte Campus[Affiliation]"
Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus.
Obes Surg
December 2021
Chief, Bariatric and Metabolic Surgery Carolinas Medical Center, Ballantyne and Gastonia Director, Atrium Health University of North Carolina-Charlotte Campus Director, Bariatric Fellowship Program Carolinas Medical Center-Mercy, Atrium Health Weight Management Charlotte, ConcordCharlotte, NC, USA.
Background: Fasting during Ramadan is one of the five pillars of the Muslim faith. Despite the positive effects of fasting on health, there are no guidelines or clear recommendations regarding fasting after metabolic/bariatric surgery (MBS). The current study reports the result of a modified Delphi consensus among expert metabolic/bariatric surgeons with experience in managing patients who fast after MBS.
View Article and Find Full Text PDFCorrection to: Biography: Abdelrahman Nimeri MD.
Obes Surg
October 2018
Department of Surgery, Carolinas Medical Center University of North Carolina Charlotte Campus, Charlotte, NC, USA.
In the original article the photo of Dr. Nimeri was inadvertently omitted. We apologize for this oversight.
View Article and Find Full Text PDFBiography: Abdelrahman Nimeri MD.
Obes Surg
September 2018
Department of Surgery, Carolinas Medical Center University of North Carolina Charlotte Campus, Charlotte, NC, USA.
Prognostic significance of X-ray cross-complementing gene 1 expression in gastric cancer.
Chin J Cancer Res
June 2016
Department of Gastroenterology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Objective: The aim of this study is to identify the prognostic significance of X-ray cross-complementing gene 1 (XRCC1) in patients with gastric cancer undergoing surgery and platinum-based adjuvant chemotherapy.
Methods: Immunohistochemistry (IHC) was used to evaluate XRCC1 protein expression profiles on surgical specimens of 612 gastric cancer patients. The relationship between XRCC1 expression and existing prognostic factors, platinum-based adjuvant chemotherapy, disease-free survival (DFS) and overall survival (OS) were analyzed.
Establishing Benchmarks For Minimum Competence With Dry Lab Robotic Surgery Drills.
J Minim Invasive Gynecol
June 2017
Department of Obstetrics and Gynecology, Lehigh Valley Health Network, Allentown, Pennsylvania.
The Robotic Objective Structured Assessment of Technical Skills (R-OSATS) is a previously validated assessment tool that is used to assess 5 standardized inanimate robotic surgery drills. R-OSATS is used to evaluate performance on surgical drills, with scores of 0 to 20 for each drill. Our objective was to establish the minimum threshold score that denotes competence on these drills.
View Article and Find Full Text PDFVedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.
Inflamm Bowel Dis
May 2015
*Robarts Clinical Trials, Robarts Research Institute, Western University, London, ON, Canada; †Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; ‡Center for Inflammatory Bowel Diseases, Richmond, Virginia; §UVA Digestive Health Center of Excellence, University of Virginia Health Systems, Charlottesville, Virginia; and ‖Carolinas Medical Center, University of North Carolina Charlotte Campus, Charlotte, North Carolina.
Background: We performed a systematic review to evaluate the efficacy and safety of vedolizumab for induction and maintenance of remission in ulcerative colitis.
Methods: A literature search to June 2014 identified all applicable randomized trials. Outcome measures were clinical and endoscopic remission, clinical and endoscopic response, quality of life, and adverse events.
Prognostic significance of ERCC1 expression in postoperative patients with gastric cancer.
Chin J Cancer Res
June 2014
1 Department of Oncology, 2 Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China ; 3 Department of Oncology, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang 330000, China ; 4 Gastroenterology, Department of Internal Medicine, Carolinas Medical Center, University of North Carolina Charlotte Campus, 1000 Blythe Blvd, Charlotte, NC 28203, USA ; 5 Department of Respiratory Medicine, 6 Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.
Article Synopsis
- This study investigated how the levels of ERCC1, a gene involved in DNA repair, relate to the survival outcomes of patients with gastric cancer after surgery.
- A total of 605 patients were analyzed, with follow-ups spanning several years, using various methods like immunohistochemistry to measure ERCC1 expression.
- The results showed no significant difference in survival based on ERCC1 levels, but chemotherapy appeared to benefit ERCC1-negative patients more, indicating that ERCC1 may help guide treatment strategies.